ProShares Ultra Nasdaq Biotechnology (BIB)

46.05
NASDAQ : Financial
Prev Close 45.95
Day Low/High 45.47 / 46.62
52 Wk Low/High 33.97 / 100.18
Avg Volume 622.50K
Exchange NASDAQ
Shares Outstanding 10.45M
Market Cap 480.18M
Div & Yield N.A. (N.A)

Latest News

Sum Up The Parts: BIB Could Be Worth $57

Sum Up The Parts: BIB Could Be Worth $57

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the ProShares Ultra Nasdaq Biotechnology ETF , we found that the implied analyst target price for the ETF based upon its underlying holdings is $57.37 per unit.

Analysts See 40% Upside For BIB

Analysts See 40% Upside For BIB

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the ProShares Ultra Nasdaq Biotechnology ETF , we found that the implied analyst target price for the ETF based upon its underlying holdings is $54.33 per unit.

The Math Shows BIB Can Go To $60

The Math Shows BIB Can Go To $60

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the ProShares Ultra Nasdaq Biotechnology ETF , we found that the implied analyst target price for the ETF based upon its underlying holdings is $59.50 per unit.

The Implied Analyst 12-Month Target For BIB

The Implied Analyst 12-Month Target For BIB

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the ProShares Ultra Nasdaq Biotechnology ETF , we found that the implied analyst target price for the ETF based upon its underlying holdings is $56.59 per unit.

First Week of April 15th Options Trading For Proshares Ultra Nasdaq Biotechnology (BIB)

First Week of April 15th Options Trading For Proshares Ultra Nasdaq Biotechnology (BIB)

Investors in Proshares Ultra Nasdaq Biotechnology saw new options become available this week, for the April 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BIB options chain for the new April 15th contracts and identified one put and one call contract of particular interest.

Analysts See 51% Gains Ahead For BIB

Analysts See 51% Gains Ahead For BIB

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the ProShares Ultra Nasdaq Biotechnology ETF , we found that the implied analyst target price for the ETF based upon its underlying holdings is $58.06 per unit.

Peek Under The Hood: BIB Has 51% Upside

Peek Under The Hood: BIB Has 51% Upside

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the ProShares Ultra Nasdaq Biotechnology ETF , we found that the implied analyst target price for the ETF based upon its underlying holdings is $60.55 per unit.

Interesting BIB Put And Call Options For March 18th

Interesting BIB Put And Call Options For March 18th

Investors in Proshares Ultra Nasdaq Biotechnology saw new options begin trading this week, for the March 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BIB options chain for the new March 18th contracts and identified one put and one call contract of particular interest.

Shares of BIB Now Oversold

Shares of BIB Now Oversold

In trading on Tuesday, shares of the ProShares Ultra Nasdaq Biotechnology ETF entered into oversold territory, changing hands as low as $45.90 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysis indicator used to measure momentum on a scale of zero to 100.

Noteworthy ETF Outflows: BIB

Noteworthy ETF Outflows: BIB

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares Ultra Nasdaq Biotechnology where we have detected an approximate $32.7 million dollar outflow -- that's a 3.6% decrease week over week (from 11,100,000 to 10,700,000). START SLIDESHOW:Click here to find out which 9 other ETFs experienced notable outflows » The chart below shows the one year price performance of BIB, versus its 200 day moving average: Looking at the chart above, BIB's low point in its 52 week range is $55.00 per share, with $189.74 as the 52 week high point — that compares with a last trade of $81.97.

ProShares Ultra Nasdaq Biotechnology Experiences Big Inflow

ProShares Ultra Nasdaq Biotechnology Experiences Big Inflow

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares Ultra Nasdaq Biotechnology where we have detected an approximate $44.9 million dollar inflow -- that's a 4.7% increase week over week in outstanding units (from 10,750,000 to 11,250,000). START SLIDESHOW:Click here to find out which 9 other ETFs had notable inflows » The chart below shows the one year price performance of BIB, versus its 200 day moving average: Looking at the chart above, BIB's low point in its 52 week range is $83.75 per share, with $189.74 as the 52 week high point — that compares with a last trade of $89.30.

Notable ETF Inflow Detected - BIB

Notable ETF Inflow Detected - BIB

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares Ultra Nasdaq Biotechnology where we have detected an approximate $67.9 million dollar inflow -- that's a 7.0% increase week over week in outstanding units (from 10,050,000 to 10,750,000). START SLIDESHOW:Click here to find out which 9 other ETFs had notable inflows » The chart below shows the one year price performance of BIB, versus its 200 day moving average: Looking at the chart above, BIB's low point in its 52 week range is $84.88 per share, with $189.74 as the 52 week high point — that compares with a last trade of $98.75.

ProShares Expands Largest Lineup Of Leveraged And Inverse ETFs

ProShares Expands Largest Lineup Of Leveraged And Inverse ETFs

ProShares, a premier provider of alternative ETFs, today announced the launch of six new geared ETFs.

ProShares Ultra Nasdaq Biotechnology Experiences Big Outflow

ProShares Ultra Nasdaq Biotechnology Experiences Big Outflow

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares Ultra Nasdaq Biotechnology where we have detected an approximate $37.8 million dollar outflow -- that's a 3.8% decrease week over week (from 10,500,000 to 10,100,000). Among the largest underlying components of BIB, in trading today Acadia Pharmaceuticals Inc is up about 0.7%, Acceleron Pharma, Inc.

ProShares Ultra Nasdaq Biotechnology Experiences Big Outflow

ProShares Ultra Nasdaq Biotechnology Experiences Big Outflow

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares Ultra Nasdaq Biotechnology where we have detected an approximate $47.8 million dollar outflow -- that's a 5.0% decrease week over week (from 11,050,000 to 10,500,000). Among the largest underlying components of BIB, in trading today Acadia Pharmaceuticals Inc is down about 1.3%, Acceleron Pharma, Inc.

Notable ETF Outflow Detected - BIB, ACAD, XLRN, ACRX

Notable ETF Outflow Detected - BIB, ACAD, XLRN, ACRX

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares Ultra Nasdaq Biotechnology where we have detected an approximate $39.8 million dollar outflow -- that's a 3.9% decrease week over week (from 11,500,000 to 11,050,000). Among the largest underlying components of BIB, in trading today Acadia Pharmaceuticals Inc is trading flat, Acceleron Pharma, Inc.

ProShares Ultra Nasdaq Biotechnology Experiences Big Inflow

ProShares Ultra Nasdaq Biotechnology Experiences Big Inflow

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares Ultra Nasdaq Biotechnology where we have detected an approximate $70.9 million dollar inflow -- that's a 8.7% increase week over week in outstanding units (from 5,150,000 to 5,600,000). Among the largest underlying components of BIB, in trading today Acadia Pharmaceuticals Inc is up about 3.7%, Acceleron Pharma, Inc.

ProShares Announces ETF Share Splits

ProShares Announces ETF Share Splits

ProShares, a premier provider of alternative ETFs, announced today forward and reverse share splits on 21 of its ETFs.

BIB, ACAD, XLRN, ACRX: ETF Inflow Alert

BIB, ACAD, XLRN, ACRX: ETF Inflow Alert

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares Ultra Nasdaq Biotechnology where we have detected an approximate $54.4 million dollar inflow -- that's a 7.4% increase week over week in outstanding units (from 4,750,000 to 5,100,000). Among the largest underlying components of BIB, in trading today Acadia Pharmaceuticals Inc is off about 1%, Acceleron Pharma, Inc.

Notable ETF Inflow Detected - BIB, XLRN, ACRX, ACHN

Notable ETF Inflow Detected - BIB, XLRN, ACRX, ACHN

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares Ultra Nasdaq Biotechnology where we have detected an approximate $76.8 million dollar inflow -- that's a 10.5% increase week over week in outstanding units (from 4,300,000 to 4,750,000). Among the largest underlying components of BIB, in trading today Acceleron Pharma, Inc.

ProShares Ultra Nasdaq Biotechnology Experiences Big Outflow

ProShares Ultra Nasdaq Biotechnology Experiences Big Outflow

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares Ultra Nasdaq Biotechnology where we have detected an approximate $93.1 million dollar outflow -- that's a 17.4% decrease week over week (from 4,300,000 to 3,550,000). Among the largest underlying components of BIB, in trading today Acadia Pharmaceuticals Inc is down about 0.6%, AcelRx Pharmaceuticals Inc is off about 0.5%, and Achillion Pharmaceuticals Inc.

ProShares Ultra Nasdaq Biotechnology Experiences Big Inflow

ProShares Ultra Nasdaq Biotechnology Experiences Big Inflow

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares Ultra Nasdaq Biotechnology where we have detected an approximate $86.6 million dollar inflow -- that's a 19.4% increase week over week in outstanding units (from 3,600,000 to 4,300,000). Among the largest underlying components of BIB, in trading today Acadia Pharmaceuticals Inc is off about 0.6%, AcelRx Pharmaceuticals Inc is up about 1.5%, and Achillion Pharmaceuticals Inc.

Notable ETF Outflow Detected - BIB, ACAD, ACRX, ACHN

Notable ETF Outflow Detected - BIB, ACAD, ACRX, ACHN

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Proshares Ultra Nasdaq Biotechnology where we have detected an approximate $80.0 million dollar outflow -- that's a 16.3% decrease week over week (from 4,300,000 to 3,600,000). Among the largest underlying components of BIB, in trading today Acadia Pharmaceuticals Inc is up about 1.3%, AcelRx Pharmaceuticals Inc is up about 3.1%, and Achillion Pharmaceuticals Inc.

Biotech Still Shines In An Uncertain Stock Market

Biotech Still Shines In An Uncertain Stock Market

Here's why quality biotech stocks are worth a serious look.

Noteworthy ETF Inflows: BIB, ACAD, ACRX, ACHN

Noteworthy ETF Inflows: BIB, ACAD, ACRX, ACHN

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Proshares Ultra Nasdaq Biotechnology where we have detected an approximate $53.7 million dollar inflow -- that's a 14.7% increase week over week in outstanding units (from 3,750,000 to 4,300,000). Among the largest underlying components of BIB, in trading today Acadia Pharmaceuticals Inc is up about 0.9%, AcelRx Pharmaceuticals Inc is up about 2%, and Achillion Pharmaceuticals Inc.

This bull market is showing signs of age

This bull market is showing signs of age

Stop-loss orders helped minimize losses during recent downturn.

BIB, ACAD, ACRX, ACHN: ETF Outflow Alert

BIB, ACAD, ACRX, ACHN: ETF Outflow Alert

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Proshares Ultra Nasdaq Biotechnology where we have detected an approximate $29.9 million dollar outflow -- that's a 8.7% decrease week over week (from 4,600,000 to 4,200,000). Among the largest underlying components of BIB, in trading today Acadia Pharmaceuticals Inc is up about 2.6%, AcelRx Pharmaceuticals Inc is off about 0.1%, and Achillion Pharmaceuticals Inc.

Why I'm bullish on 3D Systems despite pricey valuation

Why I'm bullish on 3D Systems despite pricey valuation

3D Systems is an expensive stock, but has big potential.